Meal-Based Exposure and Response Prevention in Anorexia Nervosa
- Conditions
- Anorexia Nervosa
- Interventions
- Behavioral: Exposure and Response PreventionBehavioral: Motivational Interviewing
- Registration Number
- NCT03747835
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
Patients with anorexia nervosa (AN), a serious psychiatric disorder, exhibit restricted dietary intake and endorse fear of consuming calorie-dense foods, which in turn drives weight loss. Premorbid anxious personality traits and comorbid anxiety disorders are common in patients with AN. Although intensive behavioral treatment programs can achieve weight restoration in a majority of adults with AN, relapse rates are high. Predictors of relapse include elevated state anxiety and low dietary variety, including lower intake of fat, after discharge, which suggests that relapse following weight restoration may be related to inadequate fear extinction to high energy density (ED) foods during treatment and consequent resumption of restrictive eating patterns. Despite evidence of anxiety's role in the onset and maintenance of restricted eating behavior, utilizing exposure and response prevention (EX-RP) and meal-based interventions to reduce food-related fears is understudied. EX-RP is the gold standard of treatment for Obsessive Compulsive Disorder (OCD). This proposal aims to test the efficacy of an adjunct meal-based EX-RP intervention to reduce food-related fears during intensive behavioral weight restoration in hospitalized patients with AN in comparison to a control treatment, Motivational Interviewing. The investigators will assess changes in a) self-reported anxiety regarding consumption of high-ED foods, b) physiological (skin conductance and heart rate variability) responses to imagined consumption of food items elicited utilizing a visual food cue task, and c) caloric intake of a challenging test meal pre- and post-treatment. A secondary aim is to assess the relationship of early treatment response to EX-RP, operationalized as a reduction in self-reported anxiety within the first three weeks of treatment, and end-of-treatment as well as six-month post-discharge outcomes. Helping patients tolerate food-related anxiety and increase dietary variety across meal contexts may augment treatment effectiveness in adult patients during intensive treatment for AN and has potential to decrease relapse rates.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- Meets Diagnostic and Statistical Manual of Mental Disorders (DSM) -5 criteria for AN or Other Specified Feeding and Eating Disorder.
- Body Mass Index (BMI) > 14.0 kg/m2 and < 20.0 kg/m2
- Age > 12 years, < 66 years
- Fluency in the English language
Exclusion criteria:
- Diagnosis of schizophrenia, schizophreniform disorder, bipolar illness (type I) with active psychotic symptoms
- History of traumatic brain injury with current impairment in functioning
- Current use of benzodiazepines, as these medications may alter psychophysiological assessment
- Allergy to dairy products or chocolate contained in the test meal
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Exposure and Response Prevention Exposure and Response Prevention Inpatients will be provided three 90-minute sessions of Exposure and Response Prevention therapy each week. Motivational Interviewing Motivational Interviewing Inpatients will be provided two 60-minute sessions of Motivational Interviewing each week.
- Primary Outcome Measures
Name Time Method Change in amount of high calorie diet consumption At week 2 of treatment and at discharge, up to 10 weeks Patients will be asked to consume a meal (1,066 kcal) consisting of calorie dense foods over a period of 45 minutes. Total caloric intake will be measured by weighing food items prior to and following the meal and identifying the proportion of the meal in kcal consumed.
Change in Physiological Anxiety in Response to Food Images as assessed by Skin Conductance Response Pre-treatment and post-treatment up to 10 weeks Participants will view images of low- and high-ED foods, and of office products for 8 seconds each. Skin Conductance Response (microsiemens) will be recorded from electrodes placed on the palmar surface of the middle phalanges of the 2nd and 3rd fingers on the non-dominant hand.
Change in Physiological Anxiety in Response to Food Images as assessed by Heart rate variability Pre-treatment and post-treatment up to 10 weeks Participants will view images of low- and high-ED foods, and of office products for 8 seconds each. Heart rate variability will be measured using ECG electrodes placed in a diagonal axis across the heart region, with a reference electrode on the stomach.
- Secondary Outcome Measures
Name Time Method Change in food Choice Preferences as assessed by The Food Choice Task Pre-treatment and post-treatment up to 10 weeks The Food Choice Task is a computer based task that assesses preference for low- versus high-fat food items. Patients rate food items on tastiness and healthiness and are then asked to make a series of choices regarding food preferences. The proportion of high-fat food choices made is an indication of the patient's preference for low-versus high-fat foods. A higher proportion of trials on which individuals select the high-fat food is associated with an increased willingness to consume those foods.
Eating Disorder Examination Questionnaire Scores Pre-treatment and post-treatment up to 10 weeks Patients will complete the 28-item Eating Disorder Examination Questionnaire, which includes four subscales: Eating Concern, Weight Concern, Restraint, and Shape Concern. Scores on these subscales range from 0 to 7, with higher scores indicative of more pathology.
Change in food related anxiety as assessed by the Food Anxiety Questionnaire. Weekly up to 10 weeks Patients will complete the Food Anxiety Questionnaire, which asks patients to rate their anxiety regarding consumption of 35 frequently consumed foods, using Subjective Units of Distress. Subjective Units of Distress range from 0-100, with '0' indicating no distress or anxiety and '100' indicating the highest possible level of distress or anxiety.
Trial Locations
- Locations (1)
Johns Hopkins Hospital
🇺🇸Baltimore, Maryland, United States